United States · Platforms & data · MarketBeat

Rani Therapeutics Eyes 2027 Obesity Data as Oral Biologics Platform Advances

Published by MarketBeat · United States 1 h ago

Rani Therapeutics (NASDAQ:RANI) outlined progress for its oral biologics delivery platform, including plans to advance its obesity program RT-114 and expectations for additional…

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

The Motley Fool

Forget the Anthropic IPO. Here Are 6 Stocks Worth Watching.

MarketWatch

The Social Security Administration wants more babies signed up for ‘Trump accounts.’ But there’s still a catch.

Investing.com

Bank of Korea holds rates, upbeat outlook points to future hikes

Stocktwits

FUN Stock Heads For 4th Week Of Loss: Analyst Sees 29% Downside Ahead Of Earnings As Mounting Debt, Weak Sales Loom

TheStreet

KFC rolls out 13 days of Halloween deals, but there’s a catch

CNBC